The Philippines Food and Drug Administration (FDA) issued an advisory to inform that they will not be accepting any online applications for any services, except for applications for Compassionate Special Permit (CSP) and Certificate for Customs Release (CFCR), during their system maintenance and upgrade period. Starting 05 April 2023, all FDA online services shall only […]
In consideration of the challenges brought about by the full implementation of AO 2018-002, the FDA recognizes that there is a need to provide medical device companies more time to prepare the technical documentary requirements based on the ASEAN Common submission dossier template (CSDT) in applying for CMDR. With this, the Philippines FDA issued the
If you have any questions or remarks, please feel free to send us a message.
We are here to assist you.
Fill up the form and our Team will get back to you within 24 hours
ANDAMAN MEDICAL PTE LTD (Head Office Singapore)
Tampines Junction Business Center
Level 09-02, 300 Tampines Avenue 5,
Singapore 529653
